scholarly article | Q13442814 |
P50 | author | J. Andrew McCammon | Q6104601 |
P2093 | author name string | Anthony Ivetac | |
P2860 | cites work | Predicting slow structural transitions in macromolecular systems: Conformational flooding | Q21686247 |
Canonical dynamics: Equilibrium phase-space distributions | Q21709091 | ||
Functional Selectivity and Classical Concepts of Quantitative Pharmacology | Q22242288 | ||
MUSCLE: multiple sequence alignment with high accuracy and high throughput | Q24613456 | ||
The impact of GPCR structures on pharmacology and structure-based drug design | Q24628661 | ||
Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands | Q57838214 | ||
Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor | Q71514922 | ||
Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations | Q24645752 | ||
Flexible ligand docking to multiple receptor conformations: a practical alternative | Q24650066 | ||
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist | Q24654563 | ||
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor | Q24657484 | ||
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors | Q24670735 | ||
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor | Q27646733 | ||
Crystal structure of the human beta2 adrenergic G-protein-coupled receptor | Q27648868 | ||
A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic Receptor | Q27650801 | ||
Structure of a beta1-adrenergic G-protein-coupled receptor | Q27651011 | ||
Crystal structure of opsin in its G-protein-interacting conformation | Q27652301 | ||
VMD: visual molecular dynamics | Q27860554 | ||
Comparative protein modelling by satisfaction of spatial restraints | Q27860866 | ||
GROMACS: fast, flexible, and free | Q27860998 | ||
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function | Q28254935 | ||
How many drug targets are there? | Q28276660 | ||
The MARTINI force field: coarse grained model for biomolecular simulations | Q29617215 | ||
PocketPicker: analysis of ligand binding-sites with shape descriptors. | Q30364721 | ||
Fast procedure for reconstruction of full-atom protein models from reduced representations. | Q30367164 | ||
Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble. | Q30367220 | ||
Coarse-grained MD simulations of membrane protein-bilayer self-assembly. | Q30368740 | ||
A computational procedure for determining energetically favorable binding sites on biologically important macromolecules | Q30406755 | ||
Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques | Q33403707 | ||
Structure-based discovery of beta2-adrenergic receptor ligands | Q33426241 | ||
Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase | Q33466833 | ||
Accommodating protein flexibility in computational drug design | Q33825095 | ||
Locating and characterizing binding sites on proteins | Q34066761 | ||
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery | Q34139176 | ||
Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors | Q34175711 | ||
GCRDb: a G-protein-coupled receptor database | Q34333530 | ||
Seven-transmembrane-spanning receptors and heart function | Q34503394 | ||
G protein-coupled receptor allosterism and complexing | Q34523552 | ||
Discovery of a novel binding trench in HIV integrase. | Q34546744 | ||
Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act? | Q34581080 | ||
G-protein-coupled receptors and cancer. | Q34606002 | ||
Efficacy at G-protein-coupled receptors | Q34742798 | ||
Discovery of new GPCR biology: one receptor structure at a time | Q34920862 | ||
Implications of protein flexibility for drug discovery | Q35167908 | ||
Allosteric modulators of G-protein-coupled receptors | Q35559684 | ||
Fragment-based lead discovery | Q35852295 | ||
Allosteric modulation of G protein-coupled receptors: perspectives and recent developments | Q35902519 | ||
Searching for new allosteric sites in enzymes | Q35975051 | ||
G-protein signaling: back to the future | Q36061579 | ||
Locally accessible conformations of proteins: multiple molecular dynamics simulations of crambin | Q36280885 | ||
Molecular dynamics: survey of methods for simulating the activity of proteins | Q36472758 | ||
Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation | Q36481447 | ||
An improved relaxed complex scheme for receptor flexibility in computer-aided drug design | Q36838120 | ||
Conformational complexity of G-protein-coupled receptors | Q36880905 | ||
Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats. | Q36959071 | ||
Allosteric modulation of kinases and GPCRs: design principles and structural diversity | Q37110414 | ||
Structural insights into G-protein-coupled receptor activation | Q37310590 | ||
The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction? | Q37340347 | ||
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders | Q37360436 | ||
Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders. | Q37416470 | ||
Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs. | Q37547722 | ||
Ligands, their receptors and ... plasma membranes | Q37568526 | ||
Rational design of dualsteric GPCR ligands: quests and promise | Q37688232 | ||
Stabilization of the human beta2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structure | Q40020328 | ||
The family of G‐protein‐coupled receptors | Q40439041 | ||
Identification of an allosteric binding site for Zn2+ on the beta2 adrenergic receptor | Q40693273 | ||
Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature | Q41775672 | ||
Self-assembly of a simple membrane protein: coarse-grained molecular dynamics simulations of the influenza M2 channel. | Q42943551 | ||
Computational drug design accommodating receptor flexibility: the relaxed complex scheme | Q43992973 | ||
Computational approaches to identifying and characterizing protein binding sites for ligand design | Q45327964 | ||
Accelerated molecular dynamics: a promising and efficient simulation method for biomolecules | Q46058456 | ||
Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor | Q46120520 | ||
From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-beta(2)-adrenoceptor antibody behave as antagonists | Q46208108 | ||
Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds | Q46336635 | ||
Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors | Q46699162 | ||
Crystallizing thinking about the beta2-adrenergic receptor. | Q46779816 | ||
G protein-coupled receptors. I. Diversity of receptor-ligand interactions | Q47892279 | ||
Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites. | Q48498889 | ||
Identification of hot spots within druggable binding regions by computational solvent mapping of proteins. | Q51922140 | ||
Allosteric Modulation of G Protein–Coupled Receptors | Q56115675 | ||
Insights into signaling from the β2-adrenergic receptor structure | Q56648606 | ||
GROMACS 3.0: a package for molecular simulation and trajectory analysis | Q57082068 | ||
P433 | issue | 3 | |
P921 | main subject | G protein-coupled receptor | Q38173 |
P304 | page(s) | 201-217 | |
P577 | publication date | 2010-07-05 | |
P1433 | published in | Chemical Biology and Drug Design | Q15749458 |
P1476 | title | Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach | |
P478 | volume | 76 |
Q90568175 | Advanced Methods for Accessing Protein Shape-Shifting Present New Therapeutic Opportunities |
Q36263056 | Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library |
Q31148716 | An allosteric signaling pathway of human 3-phosphoglycerate kinase from force distribution analysis |
Q64110733 | Analysis of tractable allosteric sites in G protein-coupled receptors |
Q36009999 | Bioinformatics and variability in drug response: a protein structural perspective |
Q37582165 | Cloud-based simulations on Google Exacycle reveal ligand modulation of GPCR activation pathways |
Q30521288 | Comparison of dynamics of extracellular accesses to the β(1) and β(2) adrenoceptors binding sites uncovers the potential of kinetic basis of antagonist selectivity |
Q35967903 | Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors |
Q27311564 | Computational study on the different ligands induced conformation change of β2 adrenergic receptor-Gs protein complex |
Q36072549 | Conformationally selective RNA aptamers allosterically modulate the β2-adrenoceptor. |
Q33922348 | Differences in allosteric communication pipelines in the inactive and active states of a GPCR. |
Q38795153 | Discovery of Novel Allosteric Eg5 Inhibitors Through Structure-Based Virtual Screening |
Q35926542 | Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology |
Q24633124 | Druggability Assessment of Allosteric Proteins by Dynamics Simulations in the Presence of Probe Molecules |
Q38109928 | Druggable orthosteric and allosteric hot spots to target protein-protein interactions. |
Q30358225 | Emerging Computational Methods for the Rational Discovery of Allosteric Drugs. |
Q27308091 | Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments |
Q28534702 | Expanding the druggable space of the LSD1/CoREST epigenetic target: new potential binding regions for drug-like molecules, peptides, protein partners, and chromatin |
Q30391745 | Exploration of the conformational landscape in pregnane X receptor reveals a new binding pocket |
Q27001129 | Exploring the role of receptor flexibility in structure-based drug discovery |
Q42209394 | Force distribution reveals signal transduction in E. coli Hsp90. |
Q35234897 | Identification of a novel selective serotonin reuptake inhibitor by coupling monoamine transporter-based virtual screening and rational molecular hybridization |
Q41015632 | Identification of small-molecule binding pockets in the soluble monomeric form of the Aβ42 peptide |
Q42183818 | Identification of the binding site of an allosteric ligand using STD-NMR, docking, and CORCEMA-ST calculations |
Q35977592 | Intracellular Loop 2 Peptides of the Human 5HT1a Receptor are Differential Activators of Gi. |
Q33577530 | Mapping of allosteric druggable sites in activation-associated conformers of the M2 muscarinic receptor |
Q46049863 | Mapping the allosteric sites of the A2A adenosine receptor. |
Q93087286 | Mechanism of β2AR regulation by an intracellular positive allosteric modulator |
Q34061019 | Molecular dynamics simulations and drug discovery |
Q30369875 | Molecular dynamics simulations: from structure function relationships to drug discovery. |
Q42582195 | Molecular modeling of the M3 acetylcholine muscarinic receptor and its binding site |
Q35733861 | Molecular recognition in the case of flexible targets |
Q36682460 | Multi-Scale Continuum Modeling of Biological Processes: From Molecular Electro-Diffusion to Sub-Cellular Signaling Transduction |
Q47348671 | Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs |
Q90430431 | Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations |
Q35073109 | Predictive power of molecular dynamics receptor structures in virtual screening |
Q38362491 | Principles in the design of ligand-targeted cancer therapeutics and imaging agents. |
Q39152860 | Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors |
Q26747130 | Revealing Atomic-Level Mechanisms of Protein Allostery with Molecular Dynamics Simulations |
Q38675922 | Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors. |
Q35882569 | Structure-based model of allostery predicts coupling between distant sites |
Q36604792 | The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins |
Search more.